Navigation Links
Burg Simpson Leads National Litigation Against DePuy Orthopaedics, Inc.
Date:1/28/2011

DENVER, Jan. 28, 2011 /PRNewswire/ -- Burg Simpson Eldredge Hersh & Jardine, P.C., one of the nation's leading plaintiff litigation law firms, is delighted to announce that shareholder, Seth. A. Katz, has been appointed by the Hon. David A. Katz to serve as a member of the Plaintiffs' Steering Committee in the multidistrict litigation against DePuy Orthopaedics, Inc. over the alleged failure of its ASR XL Acetabular Hip System.

In August 2010, DePuy Orthopaedics, Inc., a subsidiary of Johnson & Johnson (NYSE: JNJ), announced a voluntary recall of its ASR XL Acetabular Hip System, after reports revealed an unacceptable failure rate of the device, resulting in revision surgery for 13 percent of patients within five years. Burg Simpson has been involved in this pending litigation from the very start and, late last year, became the first firm to file lawsuits against DePuy Orthopaedics, Inc. in Colorado and Wyoming.

Speaking of his appointment, Mr. Katz said, "I am extremely honored to have been appointed to assume a leadership position in what may become one of the most high-profile litigations in recent years." Mr. Katz continued, "The evidence certainly suggests that thousands of individuals from across the country have had their health compromised due to DePuy's disregard for patient safety. Despite being aware of the problems and risks that the design of metal-on-metal joints carry and the mounting clinical evidence pointing to this problem, DePuy failed to provide adequate warnings of the health risks associated with their device to the public and the medical community. This has left our clients, and thousands of others across the country in the totally unacceptable position of having to undergo the agony and disruption of another hip replacement procedure within the next several years as well as possible systemic disease from unsafe levels of metal in their bloodstream. Our clients deserve justice and fair compensation for the pain, suffering and life-altering experience they must now live through."

Burg Simpson senior shareholder Peter W. Burg said, "At Burg Simpson, we have successfully litigated defective product, pharmaceutical and devices cases for more than 30 years in state and federal courts and in the multidistrict litigation arena. Seth's appointment to the Plaintiffs' Steering Committee is testament not only to his skills, but the ability of our firm to handle such high-profile cases. Our number one priority is to ensure that everyone of our clients injured by this device receive the appropriate level of compensation that will allow them to rebuild their lives."

With its main office in Denver, Burg Simpson Eldredge Hersh & Jardine, P.C., has been at the forefront of mass tort and multidistrict litigation for more than ten years. The firm's award-winning attorneys have been appointed to lead numerous dangerous drug cases in recent years, including litigation involving the Yasmin and Yaz birth control pills, Gadolinium based contrast agents, Ortho Evra birth control patch, ReNu with MoistureLoc contact lens solution, Vioxx, Heparin, Zyprexa, Bextra/Celebrex, Fen-Phen, and others. Burg Simpson also maintains offices in Cincinnati, Cody, and Phoenix.

www.burgsimpson.com


'/>"/>
SOURCE Burg Simpson Eldredge Hersh & Jardine, P.C.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Groundbreaking Study Proves Personalized Diet Based on Genetics Leads to Significant Advances in Long Term Weight Management and Blood Glucose Levels
2. Providence Hospital Study Finds Communication System Leads to Faster Heart Attack Treatment
3. Discovery Leads to Earlier Diagnosis of Type 1 Diabetes
4. Pharmaleads Lead Candidate for Pain, PL37, Enters Phase I
5. Texas Back Institute Leads Way in New Facet Joint Clinical Trial
6. Genetic Research Leads to New Discovery in Understanding Rare Neurological Disorder
7. San Ramon HR Firm Leads Response to New Cal/OSHA ATD Law
8. BodySculpt(TM) Leads FDA Approval of BodyTite(TM) with Largest Number of Documented Study Cases
9. Medical Equipment Company Owner Pleads Guilty to Fraud Scheme Involving Nutritional Supplies and "Arthritis Kits"
10. Los Angeles Business Owner Pleads Guilty to Submitting Nearly $1 Million in False and Fraudulent Claims to Medicare
11. Colombian National Pleads Guilty to Role in Defrauding the Export-Import Bank of the United States of More Than $1 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a ... targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , ...
(Date:9/13/2017)... , Sept. 13, 2017   OrthoAtlanta has been ... Atlanta Football Host Committee (AFHC) for the 2018 College Football ... 8, 2018, at Mercedes-Benz Stadium in Atlanta, Georgia ... the AFHC "I,m In" campaign, participating in many activities leading ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Yisrayl Hawkins, ... week that explains one of the most popular and least understood books in the ... cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed it ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains ... possible to save lost souls in the Philippines. “The Journey: From the Mountains to ... dedicated teacher of the Bible. She has taught all ages and currently teaches a ...
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
(Date:10/12/2017)... ... ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s premier ... of the shoulder pad. The shoulder pad provides optimal support and full contact ... using cold therapy. By utilizing ice and water that is circulated from an insulated ...
(Date:10/12/2017)... Maryland (PRWEB) , ... October 12, 2017 , ... ... magnetic drug delivery system that we intend to develop to enable prevention of ... can lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing ...
Breaking Medicine News(10 mins):